The results showed that the AUC values were consistently near or exceeded 0.7 in all three datasets, suggesting the potential ability of COL6A3 and FKBP10 to distinguish patients with AF and CAD from controls (Fig. 6). This evidence concerns the gene COL6A3 and coronary artery disorder.